Literature DB >> 32553174

Caspase-8 and FADD: Where Cell Death and Inflammation Collide.

Marcelo Pires Amaral1, Karina Ramalho Bortoluci2.   

Abstract

Caspase-8 is a master regulator of cell death pathways, although its regulation during inflammation remains elusive. Using elegant mouse genetic approaches, Schwarzer et al. and Tummers et al. revealed the importance of FADD in regulating caspase-8-mediated inflammatory responses and gut homeostasis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32553174     DOI: 10.1016/j.immuni.2020.05.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  3 in total

1.  Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials.

Authors:  Andrés López-Cortés; Santiago Guerrero; Esteban Ortiz-Prado; Verónica Yumiceba; Antonella Vera-Guapi; Ángela León Cáceres; Katherine Simbaña-Rivera; Ana María Gómez-Jaramillo; Gabriela Echeverría-Garcés; Jennyfer M García-Cárdenas; Patricia Guevara-Ramírez; Alejandro Cabrera-Andrade; Lourdes Puig San Andrés; Doménica Cevallos-Robalino; Jhommara Bautista; Isaac Armendáriz-Castillo; Andy Pérez-Villa; Andrea Abad-Sojos; María José Ramos-Medina; Ariana León-Sosa; Estefanía Abarca; Álvaro A Pérez-Meza; Karol Nieto-Jaramillo; Andrea V Jácome; Andrea Morillo; Fernanda Arias-Erazo; Luis Fuenmayor-González; Luis Abel Quiñones; Nikolaos C Kyriakidis
Journal:  Front Pharmacol       Date:  2022-03-29       Impact factor: 5.810

2.  SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.

Authors:  Shufen Li; Yulan Zhang; Zhenqiong Guan; Huiling Li; Meidi Ye; Xi Chen; Jun Shen; Yiwu Zhou; Zheng-Li Shi; Peng Zhou; Ke Peng
Journal:  Signal Transduct Target Ther       Date:  2020-10-09

Review 3.  Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies.

Authors:  Thomas A Premeaux; Stephen T Yeung; Zaheer Bukhari; Scott Bowler; Oral Alpan; Raavi Gupta; Lishomwa C Ndhlovu
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.